Kentucky Settles Two Pharmaceutical Cases For $39.5M
January 7, 2016
The Attorney General of Kentucky announced on December 23, 2015 that Kentucky had settled two pharmaceutical cases on December 22, 2015 that it had brought against Purdue Pharma regarding its opiod prescription medication, OxyContin, and against Janssen Pharmaceuticals, a subsidiary of Johnson &am[...]
Continue Reading
Zofran Lawsuit Alleges Serious Birth Defects
November 12, 2015
On September 29, 2015, a federal lawsuit was filed in California by the parents of a child born with a serious heart defect that they contend was caused by the mother’s off-label use of Zofran that was prescribed by her doctor for nausea during her pregnancy. The defendant is GlaxoSmithKline [...]
Continue Reading
Pradaxa Reversal Agent Approved
November 3, 2015
In 2010, the FDA approved the prescription blood-thinning drug Pradaxa (dabigatran) to prevent stroke and systemic blood clots in patients with atrial fibrillation, as well as for the treatment and prevention of deep venous thrombosis and pulmonary embolism. On October 16, 2015, the FDA granted acc[...]
Continue Reading
First Tylenol Liver Damage Trial Ends In Defense Verdict
October 29, 2015
On October 16, 2015, a jury in New Jersey absolved Johnson and Johnson’s McNeil Consumer Healthcare subsidiary from liability to the plaintiff for her liver damage allegedly caused by taking Tylenol (acetaminophen), after a three-week trial. The 55-year-old plaintiff had alleged that the manu[...]
Continue Reading
Maryland Pill Mill Guilty Plea
October 24, 2015
An 82-year-old Florida man pleaded guilty on October 15, 2015 in federal court in Maryland to conspiracy to distribute oxycodone and other drugs at a pill mill in Maryland. According to the defendant’s plea agreement, the Maryland pill mill was an off-shoot of the Florida pill mill that he [...]
Continue Reading
Dangers Of Coumadin For Nursing Homes Residents
August 12, 2015
On July 17, 2015, the Centers for Medicare and Medicaid Services sent a memo to state health departments warning of the danger of misuse of the common blood-thinner Coumadin for nursing home residents, requesting that state health inspectors pay increased attention to errors by nursing homes in m[...]
Continue Reading